Middle hepatic vein variation provides a safe path for anterior transection of hepatocellular carcinoma in caudate lobe  

作　　者：Bing-Yi Lin Qi-Jun Zhang Zhe Yang Shu-Sen Zheng 

机构地区：[1]Department of Hepatobiliary and Pancreatic Surgery,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China [2]Department of Thyroid Surgery,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China [3]Division of Hepatobiliary Pancreatic Surgery,Shulan(Hangzhou)Hospital,Zhejiang Shuren University School of Medicine,Hangzhou 310000,China

出　　处：《Hepatobiliary & Pancreatic Diseases International》2024年第4期438-440,共3页国际肝胆胰疾病杂志（英文版）

基　　金：the Natural Science Foundation of Zhejiang Province(LQ22H160058).

摘　　要：To the Editor:Hepatocellular carcinoma(HCC)is one of the main causes of cancer related death worldwide,and new cases are expected to continue to increase in future[1].Surgical resection is still the best way to remove the tumor and improve patient’s prognosis.However,resection of caudate lobe often presents a technical challenge,even to accomplished hepatic surgeons.Caudate lobe is located anterior to the inferior vena cava(IVC)and posterior to the bifurcation of the portal vein(PV),generally consists of three regions:the paracaval portion,the left Spiegel lobe and the process portion[2].The anatomy of the paracaval portion includes the liver parenchyma ventral to the hepatic IVC and the area between the Spiegel lobe and the right lobe adjacent to the middle hepatic vein(MHV)ventrally,which was classified by Couinaud as segment IX[3].Here,we presented a case of HCC with successful downstaging therapy,as well as variation of MHV,which provides a safe path for anterior transection of segment IX.

关 键 词：HEPATIC ANATOMY MIDDLE 

分 类 号：R735.7[医药卫生—肿瘤]